HNN3.0
Register
Register
Register

Mimark Diagnostics S.L

Company (SME)

www.mimark.esBarcelona, Spain
3 profile visits

About

Mimark is a women-led biotechnology spin-off based in Barcelona, dedicated to transforming gynecological diagnostics through innovative, minimally invasive diagnostic solutions.

Mimark is pioneering the use of gynecological fluids as a novel source of biomarkers for the development of next-generation in vitro diagnostic (IVD) tests. Through its proprietary GyLDa platform, the company combines advanced proteomics, biomarker discovery, and immunoassay development to unlock the diagnostic potential of gynecological fluids and address significant unmet clinical needs in women’s health.

Our lead product, GyLDEC, is an innovative IVD test designed to improve the diagnosis of endometrial cancer through the detection of a panel of protein biomarkers in uterine fluid, aiming to reduce unnecessary invasive procedures and improve clinical decision-making.

Building on the same technological platform, Mimark is also developing GyLDEndo, a novel diagnostic solution targeting endometriosis, with the ambition of improving diagnostic pathways and addressing the challenges associated with delayed diagnosis.

Mimark is committed to advancing precision diagnostics in women’s healthcare and actively seeks strategic partnerships and collaborative R&D opportunities to accelerate technological development, clinical validation, and market adoption.

Social media

Representatives

Head of Business Development & Innovation

Mimark Diagnostics S.L